Ivana K. Kim, MD
|Co-Director, Macular Degeneration Unit|
Macular Degeneration Unit
243 Charles Street
Boston, MA 02114
|Office Hours:||Monday afternoons, Wednesday mornings, Thursday afternoons|
|Medical School||Harvard Medical School|
|Residency||Harvard Medical School, Mass. Eye and Ear (Ophthalmology)|
|Fellowship||Mass. Eye and Ear (Vitreoretinal Surgery)|
|Teaching Affiliation||Associate Professor in Ophthalmology, Harvard Medical School|
Diseases and surgery of the retina and vitreous, diabetic retinopathy, macular degeneration, retinal detachment
Macular degeneration, ocular angiogenesis, molecular genetics of uveal melanoma
Heier JS, Brown D, Ciulla T, Abraham P, Bankert JM, Chong S, Daniel PE Jr, Kim IK. Ranibizumab for choroidal neovascularization secondary to causes other than age-related macular degeneration: a phase I clinical trial. Ophthalmology. 2011 Jan; 118(1): 111-8.
To learn more about Dr. Kim, click here to read her “Meet a Specialist” profile.
Page updated December 6, 2013